ASCO GUIDELINES Bundle

Late-Stage Colorectal Cancer

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475470

Contents of this Issue

Navigation

Page 15 of 23

16 Table 6. Recommendations on Second-Line Systemic Colorectal Metastatic Treatment Note: is table pertains to Enhanced and Maximal settings, with presumption of lack of chemotherapy in other settings. Population Rec # Received oxaliplatin in first line 3.1 Received irinotecan in first line 3.2 No bevacizumab in first line 3.3 Received bevacizumab in first line 3.4 RAS WT, received anti-EGFR in first line 3.5 BRAF V600E MUT 3.6 dMMR or MSI-high 3.7 Treatment

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Late-Stage Colorectal Cancer